ContractParticipating Site Agreement • April 2nd, 2014
Contract Type FiledApril 2nd, 2014AMENDMENT 1to the PARTICIPATING SITE AGREEMENT A Prospective Observational Study with protocol entitled: “LUMINOUS: Study to observe the effectiveness and safety of LUCENTIS® through individualized patient treatment and associated outcomes” Hereinafter: “the Study” BetweenFNsP F.D.Roosevelta, with address at Nám. L.Svobodu 1, 975 17 Banská Bystrica, Slovakia (hereinafter referred to as “Clinician Site”), AndDr. Mária Molnárová, with the address at FNsP F.D.Roosevelta, Nám. L.Svobodu 1, 975 17 Banská Bystrica, Slovakia(hereinafter referred to as “Investigator”), AndOutcome Europe SàrlCh. Du Glapin 61162, St.-Prex, Switzerland Hereinafter: “Company”(the parties hereinafter referred to as individually the “party” and jointly as the “parties”). WHEREAS, on June 27, 2012, the parties entered into the Participating Site Agreement for a Prospective Observational Study entitled Luminous for the conduct of the Study (the “Agreement”);¨ WHEREAS, Dr. Mária Molnárová has been designated as the pri